Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-methyl-5-n-(3-(7h-purin-6-yl)pyridin-2-yl)-1-n-(3-(trifluoromethoxy)phenyl)isoquinoline-1,5-diamine
2. Lut014
1. Lut014
2. 2274819-46-2
3. Lut-014
4. T4e4i523ry
5. Lut-014 [who-dd]
6. 6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]-1-n-[3-(trifluoromethoxy)phenyl]isoquinoline-1,5-diamine
7. 1,5-isoquinolinediamine, 6-methyl-n5-(3-(9h-purin-6-yl)-2-pyridinyl)-n1-(3-(trifluoromethoxy)phenyl)-
8. 1,5-isoquinolinediamine, 6-methyl-n5-[3-(9h-purin-6-yl)-2-pyridinyl]-n1-[3-(trifluoromethoxy)phenyl]-
9. Unii-t4e4i523ry
10. Schembl22356326
11. Gtpl11568
12. Ex-a2985
13. Zqd81946
14. Mfcd32062738
15. Zb1544
16. Ac-35618
17. Hy-111940
18. Cs-0094163
19. D81245
20. N5-(3-(9h-purin-6-yl)pyridin-2-yl)-6-methyl-n1-(3-(trifluoromethoxy)phenyl)isoquinoline-1,5-diamine
| Molecular Weight | 528.5 g/mol |
|---|---|
| Molecular Formula | C27H19F3N8O |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 6 |
| Exact Mass | 528.16339175 g/mol |
| Monoisotopic Mass | 528.16339175 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 808 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
78
PharmaCompass offers a list of LUT-014 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LUT-014 manufacturer or LUT-014 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LUT-014 manufacturer or LUT-014 supplier.
PharmaCompass also assists you with knowing the LUT-014 API Price utilized in the formulation of products. LUT-014 API Price is not always fixed or binding as the LUT-014 Price is obtained through a variety of data sources. The LUT-014 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LUT-014 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LUT-014, including repackagers and relabelers. The FDA regulates LUT-014 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LUT-014 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LUT-014 supplier is an individual or a company that provides LUT-014 active pharmaceutical ingredient (API) or LUT-014 finished formulations upon request. The LUT-014 suppliers may include LUT-014 API manufacturers, exporters, distributors and traders.
LUT-014 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LUT-014 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LUT-014 GMP manufacturer or LUT-014 GMP API supplier for your needs.
A LUT-014 CoA (Certificate of Analysis) is a formal document that attests to LUT-014's compliance with LUT-014 specifications and serves as a tool for batch-level quality control.
LUT-014 CoA mostly includes findings from lab analyses of a specific batch. For each LUT-014 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LUT-014 may be tested according to a variety of international standards, such as European Pharmacopoeia (LUT-014 EP), LUT-014 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LUT-014 USP).
